Understanding Immune Responses to COVID-19 Vaccines
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 1224
Special Issue Editor
Interests: viral (HPV) carcinogenesis; oxidative stress; ultraviolet radiation; skin carcinogenesis; cancer progression; cancer microenvironment; proteins' oxidation and carcinogenesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The availability of safe and effective vaccines for the SARS-CoV-2 virus proved crucial in containing and mitigating the COVID-19 pandemic globally. Despite the significant work conducted by the scientific and social communities and the great results achieved in containing the disease, there is a long way to go. Several critical biological and clinical issues must be addressed, including the emergence of variants and the short duration of protective immunity. These issues are not the only critical areas of inquiry, and questions relating to patients with disabilities, patients in critical age groups, and other frail individuals are yet to be adequately addressed.
To discuss and share the latest research results and develop new ideas, we are launching a Special Issue, entitled ‘Understanding Immune Responses to COVID-19 Vaccines’ which is actually the 2nd edition of ‘Immune Responses to COVID-19 Vaccines’.
Dr. Federico De Marco
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- variants and the short duration of protective immunity
- immune responses
- COVID-19 vaccines
Related Special Issue
- Immune Responses to COVID-19 Vaccines in Vaccines (15 articles)
